In connection with the modified agreement, Pacific Biosciences said that it will still receive feedback, input, and insight from Invitae regarding the planned development of its new sequencing systems, but Invitae has no contractual rights to take part in decisions on the development program for the sequencing systems.
The company said that Invitae will not be required to pay to Pacific Biosciences for development costs. Additionally, the company said that it will supply Invitae credits and discounts linked to Invitae's planned purchase of sequencing systems, in consideration of development costs Invitae paid to the company under the original agreement.
Price: 4.45, Change: +0.03, Percent Change: +0.68
|-- Earnings Flash (ANY) SPHERE 3D Posts Q2 Revenue $...|
|-- Earnings Flash (AWX) AVALON HOLDINGS CORPORATION ...|
|-- Earnings Flash (IKT) INHIBIKASE THERAPEUTICS Repo...|
|Research Alert: CFRA Retains Hold Opinion On Shares ...|
|US Stocks Climb as Inflation Expectations Wane|